NEW ORLEANS, LOUISIANA – At the 86th Scientific Sessions of the American Diabetes Association (ADA) held in New Orleans, Louisiana,…
Read More
Revolution Medicines’ Daraxonrasib Achieves Landmark Survival Extension in Pancreatic Cancer, Heralding New Era of Targeted Therapy
The field is ecstatic about the prospect of a targeted therapy meaningfully extending overall survival in pancreatic cancer. The 2026…
Read More
Quantum Metasurface Integration Breakthrough Achieves Twenty-Fold Efficiency Gain in Terahertz Radiation Detection
The detection of electromagnetic radiation across various spectra serves as the backbone of modern technological infrastructure, facilitating everything from fiber-optic…
Read More
International Research Team Achieves Breakthrough in Long Distance Quantum Key Distribution Using Semiconductor Quantum Dots and Time Bin Encoding
The landscape of global cybersecurity is on the precipice of a paradigm shift as researchers move closer to realizing a…
Read More
Lilly’s triple agonist achieves 16.8% weight loss in phase 3 trial
Eli Lilly and Company today announced groundbreaking results from a Phase 3 clinical trial for its investigational triple agonist, retatrutide,…
Read More
Eli Lilly’s Triple Agonist Achieves 16.8% Weight Loss in Phase 3 Trial
Eli Lilly and Company today announced groundbreaking results from a Phase 3 clinical trial for its investigational triple agonist, retatrutide,…
Read More
Lilly’s triple agonist achieves 16.8% weight loss in phase 3 trial.
Eli Lilly and Company today announced groundbreaking results from a Phase 3 clinical trial for its investigational triple agonist, retatrutide,…
Read More
Breakthrough in MXene Synthesis Achieves Unprecedented Electrical Conductivity and Surface Precision Through Novel Molten Salt Technique
A collaborative research effort led by the Institute of Ion Beam Physics and Materials Research at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR)…
Read More
Lilly’s triple agonist achieves 16.8% weight loss in phase 3 trial
Eli Lilly’s investigational drug, retatrutide, a pioneering first-in-class GIP, GLP-1, and glucagon triple hormone receptor agonist, has delivered extraordinary results…
Read More
Breakthrough in MXene Synthesis Achieves Unprecedented Electrical Conductivity and Surface Precision Through Novel Molten Salt Technique
A collaborative research effort led by the Institute of Ion Beam Physics and Materials Research at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR)…
Read More
